1. Home
  2. ACTU vs USAU Comparison

ACTU vs USAU Comparison

Compare ACTU & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • USAU
  • Stock Information
  • Founded
  • ACTU 2015
  • USAU N/A
  • Country
  • ACTU United States
  • USAU United States
  • Employees
  • ACTU N/A
  • USAU N/A
  • Industry
  • ACTU
  • USAU Precious Metals
  • Sector
  • ACTU
  • USAU Basic Materials
  • Exchange
  • ACTU NYSE
  • USAU Nasdaq
  • Market Cap
  • ACTU 135.0M
  • USAU 126.8M
  • IPO Year
  • ACTU 2024
  • USAU N/A
  • Fundamental
  • Price
  • ACTU $11.90
  • USAU $11.57
  • Analyst Decision
  • ACTU Strong Buy
  • USAU Strong Buy
  • Analyst Count
  • ACTU 1
  • USAU 2
  • Target Price
  • ACTU $20.00
  • USAU $12.50
  • AVG Volume (30 Days)
  • ACTU 68.4K
  • USAU 353.3K
  • Earning Date
  • ACTU 05-15-2025
  • USAU 07-28-2025
  • Dividend Yield
  • ACTU N/A
  • USAU N/A
  • EPS Growth
  • ACTU N/A
  • USAU N/A
  • EPS
  • ACTU N/A
  • USAU N/A
  • Revenue
  • ACTU N/A
  • USAU N/A
  • Revenue This Year
  • ACTU N/A
  • USAU N/A
  • Revenue Next Year
  • ACTU N/A
  • USAU N/A
  • P/E Ratio
  • ACTU N/A
  • USAU N/A
  • Revenue Growth
  • ACTU N/A
  • USAU N/A
  • 52 Week Low
  • ACTU $5.51
  • USAU $4.71
  • 52 Week High
  • ACTU $11.99
  • USAU $12.00
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • USAU 60.40
  • Support Level
  • ACTU N/A
  • USAU $10.40
  • Resistance Level
  • ACTU N/A
  • USAU $11.44
  • Average True Range (ATR)
  • ACTU 0.00
  • USAU 0.54
  • MACD
  • ACTU 0.00
  • USAU 0.05
  • Stochastic Oscillator
  • ACTU 0.00
  • USAU 98.38

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About USAU U.S. Gold Corp.

U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.

Share on Social Networks: